Guardant Health
GH
#1172
Rank
NZ$35.21 B
Marketcap
NZ$265.56
Share price
-2.17%
Change (1 day)
210.90%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

Earnings for Guardant Health (GH)

Earnings in 2026 (TTM): -NZ$0.75 Billion

According to Guardant Health 's latest financial reports the company's current earnings are NZ$1.08 Billion. In 2025 the company made an earning of -NZ$0.74 Billion, an increase over its 2024 earnings that were of -NZ$0.77 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Guardant Health from 2018 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -NZ$0.75 Billion0.73%
2025 -NZ$0.74 Billion-4.03%
2024 -NZ$0.77 Billion-9.12%
2023 -NZ$0.85 Billion-26.73%
2022 -NZ$1.16 Billion69.96%
2021 -NZ$0.68 Billion56.35%
2020 -NZ$0.44 Billion252.69%
2019 -NZ$0.13 Billion-17.22%
2018 -NZ$0.15 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Neogen
NEOG
-NZ$1.11 Billion 44.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Natera
NTRA
-NZ$0.51 Billion-34.13%๐Ÿ‡บ๐Ÿ‡ธ USA